Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
Multiple locations, including PhoenixThis summary needs review. Please check the official study record and contact the research team for details.
In BostonThis summary needs review. Please check the official study record and contact the research team for details.
In New York
This study is looking at whether Cognitive behaviour therapy/drug treatments can help people with Neurosciences, psychiatry, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
In StanfordThis study exists to explore whether the medication Electrophysiological could improve care and understanding. Researchers are trying to understand whether the medication Electrophysiological can improve attention, thinking, or day-to-day functioning.
In NiceThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Besançon
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including La JollaThis observational study is following people with Schizophrenia to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
In MontpellierThis study exists to compare options and see whether the medication ITI-1284 offers something meaningfully different. Researchers are trying to understand whether the medication ITI-1284 can give earlier or clearer feedback during care.
Multiple locations, including ChandlerThis study exists to compare options and see whether the medication ITI-1284 offers something meaningfully different. Researchers are trying to understand whether the medication ITI-1284 can give earlier or clearer feedback during care.
Multiple locations, including BirminghamThis study is looking at care and outcomes for people with Psychosis, Schizophrenia, At-risk Mental State, or Language Disorders. Some participants may receive healthy controls instead of the study treatment, and direct benefit is not guaranteed.
In LaxouHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.